益佰制药

- 600594

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
益佰制药(600594) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入116,819.1457,264.61282,056.10213,683.43147,970.14
营业收入116,819.1457,264.61282,056.10213,683.43147,970.14
二、营业总成本126,538.5663,520.37262,142.58193,020.82131,699.83
营业成本43,867.7722,576.3386,109.6362,780.5842,561.52
营业税金及附加1,652.89949.954,265.873,394.352,313.56
销售费用58,164.6329,218.54123,844.0693,675.6465,098.52
管理费用16,390.657,689.0935,147.8124,676.5716,630.98
财务费用1,247.73806.881,560.481,108.40258.26
研发费用5,214.892,279.5811,214.737,385.284,836.99
资产减值损失----------
公允价值变动收益----------
投资收益15.025.872.8711.312.39
其中:对联营企业和合营企业的投资收益15.286.13-34.21-25.77-20.31
汇兑收益----------
三、营业利润-10,643.22-6,773.1213,735.8019,930.7915,574.36
加:营业外收入54.542.94479.31120.1819.60
减:营业外支出813.78206.40983.04560.22229.73
其中:非流动资产处置损失----------
四、利润总额-11,402.45-6,976.5713,232.0719,490.7515,364.23
减:所得税费用-305.06164.614,096.363,340.763,191.39
五、净利润-11,097.40-7,141.189,135.7116,149.9912,172.84
归属于母公司所有者的净利润-10,649.34-6,845.4810,339.9016,987.0012,790.60
少数股东损益-448.05-295.70-1,204.19-837.01-617.77
六、每股收益
基本每股收益(元/股)-0.1340-0.08600.13100.21500.1620
稀释每股收益(元/股)-0.1340-0.08600.13100.21500.1620
七、其他综合收益3.953.95-34.36-34.36--
八、综合收益总额-11,093.44-7,137.229,101.3516,115.6312,172.84
归属于母公司所有者的综合收益总额-10,645.39-6,841.5310,305.5416,952.6312,790.60
归属于少数股东的综合收益总额-448.05-295.70-1,204.19-837.01-617.77
下载全部历史数据到excel中 返回页顶